[Sézary syndrome with terminal evolution in acute myeloblastic leukemia].
D000368:Aged; D000970:Antineoplastic Agents / Q000009:adverse effects / Q000627:therapeutic use; D006801:Humans; D007165:Immunosuppression Therapy / Q000009:adverse effects; D015470:Leukemia, Myeloid, Acute / Q000209:etiology*; D008297:Male; D011241:Prednisone / Q000627:therapeutic use; D012751:Sezary Syndrome / Q000150:complications* / Q000188:drug therapy
D000970:Antineoplastic Agents; D011241:Prednisone
Sindrome di Zézary con evoluzione terminale in leucosi acuta mieloblastica.